FCMI
Foresite Capital Management III Portfolio holdings
AUM
$37.9M
1-Year Return
6.87%
This Quarter Return
+4.73%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
–
AUM
$306M
AUM Growth
+$45.6M
(+17%)
Cap. Flow
+$57.6M
Cap. Flow
% of AUM
18.82%
Top 10 Holdings %
Top 10 Hldgs %
85.78%
Holding
34
New
9
Increased
9
Reduced
4
Closed
8
Top Buys
| 1 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$18.6M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$15.6M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$10.1M |
| 4 |
Forte Biosciences
FBRX
|
$9.06M |
| 5 |
VRNA
Verona Pharma
VRNA
|
$7.15M |
Top Sells
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$5.75M |
| 2 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$5.43M |
| 3 |
Protagonist Therapeutics
PTGX
|
$4.44M |
| 4 |
Aclaris Therapeutics
ACRS
|
$4.18M |
| 5 |
iRhythm Technologies
IRTC
|
$2.63M |
Sector Composition
| 1 | Healthcare | 44.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Abeona Therapeutics
ABEO
$352M
| $117K | 0.04% |
+733
| New | +$117K |
|
|
27
Aclaris Therapeutics
ACRS
$224M
| – | – |
-140,000
| Closed | -$4.18M |
|
|
28
iRhythm Technologies
IRTC
$5.85B
| – | – |
-70,010
| Closed | -$2.63M |
|
29
Intellia Therapeutics
NTLA
$1.25B
| – | – |
-150,000
| Closed | -$2.11M |
|
30
Natera
NTRA
$22.9B
| – | – |
-285,731
| Closed | -$2.53M |
|
|
31
Protagonist Therapeutics
PTGX
$3.71B
| – | – |
-346,281
| Closed | -$4.44M |
|
|
JNCE
32
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| – | – |
-91,600
| Closed | -$2.01M |
|
|
MNTA
33
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| – | – |
-430,632
| Closed | -$5.75M |
|
|
BOLD
34
DELISTED
Audentes Therapeutics, Inc
BOLD
| – | – |
-66,553
| Closed | -$1.13M |
|